These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 10521976

  • 1. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
    Oka M, Hazama S, Takahashi M, Yamamoto K, Abe T, Yoshino S, Hayashi H, Tangoku A.
    Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The soluble interleukin-2 receptor--a marker for squamous cell carcinoma of the upper aerodigestive tract.
    Gottschlich S, Görögh T, Lippert BM, Niemann AM, Folz BJ, Werner JA.
    Anticancer Res; 1997; 17(4B):2921-2. PubMed ID: 9329564
    [Abstract] [Full Text] [Related]

  • 9. [The level of soluble interleukin 2 receptor in esophageal carcinoma patients before and after radiotherapy].
    Liu X, An H, Jiang Y.
    Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):97-9. PubMed ID: 7656815
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data.
    Ferdeghini M, Gadducci A, Prontera C, Marrai R, Malagnino G, Annicchiarico C, Fioretti P, Bianchi R.
    Anticancer Res; 1993 Mar; 13(3):709-13. PubMed ID: 8317901
    [Abstract] [Full Text] [Related]

  • 12. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y, Tsurumi H, Sawada M, Yamada T, Hara T, Fukuno K, Goto H, Moriwaki H.
    Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
    [Abstract] [Full Text] [Related]

  • 13. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S, Shiota G, Kawasaki H.
    Hepatogastroenterology; 2003 Aug; 50(53):1569-74. PubMed ID: 14571788
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
    Gadducci A, Ferdeghini M, Malagnino G, Prontera C, Fanucchi A, Annicchiarico C, Bianchi R, Fioretti P, Facchini V.
    Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of serum biological markers in patients with hepatocellular carcinoma.
    Parasole R, Izzo F, Perrone F, Pignata S, Galati MG, Leonardi E, Castiglione F, Orlando R, Castello G, Esposito G, Gallo C, Daniele B.
    Clin Cancer Res; 2001 Nov; 7(11):3504-9. PubMed ID: 11705869
    [Abstract] [Full Text] [Related]

  • 17. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
    Boyano MD, Garcia-Vázquez MD, López-Michelena T, Gardeazabal J, Bilbao J, Cañavate ML, Galdeano AG, Izu R, Díaz-Ramón L, Raton JA, Díaz-Pérez JL.
    Br J Cancer; 2000 Oct; 83(7):847-52. PubMed ID: 10970683
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of soluble interleukin-2 receptor in patients with ANCA-associated vasculitis.
    Arranz O, Ara J, Rodríguez R, Saurina A, Mirapeix E, Darnell A.
    J Nephrol; 2000 Oct; 13(1):59-64. PubMed ID: 10720216
    [Abstract] [Full Text] [Related]

  • 19. Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications.
    Wasik MA, Vonderheid EC, Bigler RD, Marti R, Lessin SR, Polansky M, Kadin ME.
    Arch Dermatol; 1996 Jan; 132(1):42-7. PubMed ID: 8546482
    [Abstract] [Full Text] [Related]

  • 20. Soluble immunological parameters and early prognosis of renal cell cancer patients.
    Kallio JP, Tammela TL, Marttinen AT, Kellokumpu-Lehtinen PL.
    J Exp Clin Cancer Res; 2001 Dec; 20(4):523-8. PubMed ID: 11876546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.